Reactive Oxygen Species and Photobiomodulation: Mechanisms, Effects, and Implications
Reactive oxygen species (ROS) are highly reactive molecules derived from molecular oxygen which play a pivotal role in cellular signaling and homeostasis. Photobiomodulation (PBM), a non-invasive therapy utilizing red and near-infrared LASER light, modulates ROS levels to influence tissue repair and inflammation. This article explores the nature of ROS, their dual role in tissue health, the mechanisms by which PBM generates ROS, the beneficial effects of PBM-induced ROS, and potential adverse effects. Drawing on recent scientific literature, the discussion highlights PBM's therapeutic potential while emphasizing the importance of dosage control to avoid oxidative damage. The article synthesizes evidence from in vitro, in vivo, and clinical studies to provide a comprehensive overview.
Reactive Oxygen Species
ROS are essential yet potentially harmful molecules whose modulation by PBM offers significant therapeutic promise.
Introduction
Reactive oxygen species (ROS) have long been recognized as double-edged swords in biological systems, capable of both facilitating essential cellular processes and inducing pathological damage when imbalanced. In recent years, photobiomodulation (PBM) – commonly called ‘laser therapy’ - has emerged as a promising therapeutic modality that interacts with ROS to promote healing and reduce inflammation. PBM involves the application of low-intensity LASER light in the red (600–700 nm) and near-infrared (700–1000 nm) spectra to stimulate cellular functions without causing thermal damage. This therapy has applications in wound healing, pain management, and neurodegenerative diseases, largely through its modulation of mitochondrial activity and ROS production.
The interplay between ROS and PBM is particularly intriguing because PBM can either elevate or attenuate ROS levels depending on cellular context, leading to biphasic effects.
What are ROS?
What is their role in tissue health?
How does PBM produce ROS?
What are the effects of ROS produced by PBM?
And are there any adverse effects associated with ROS produced by PBM?
1. What Are Reactive Oxygen Species (ROS)?
Reactive oxygen species (ROS) encompass a diverse group of highly reactive chemical entities derived from molecular oxygen (O₂). These include free radicals such as superoxide anion (O₂⁻•), hydroxyl radical (OH•), and non-radical molecules like hydrogen peroxide (H₂O₂) and singlet oxygen (¹O₂). ROS are generated endogenously through various cellular processes, primarily as byproducts of mitochondrial electron transport during aerobic respiration, but also via enzymatic reactions involving oxidases like NADPH oxidase and xanthine oxidase.
The term "ROS" was coined to describe oxygen-derived species that are more reactive than ground-state O₂, often featuring unpaired electrons that confer their instability and reactivity. For instance, superoxide is produced when O₂ accepts a single electron, while hydrogen peroxide arises from the dismutation of superoxide or direct two-electron reduction of O₂. These molecules can react with lipids, proteins, and nucleic acids, altering their structure and function.
ROS production is tightly regulated by cellular antioxidants, including enzymes such as superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx), as well as non-enzymatic scavengers like vitamins C and E. Imbalances in this system lead to oxidative stress, a state where ROS overwhelm antioxidant defenses. Quantitatively, basal ROS levels in cells are maintained at low concentrations (e.g., 10-100 nM for H₂O₂), but can surge during stress responses.
In summary, ROS are not merely destructive agents but integral components of cellular metabolism, with their reactivity stemming from oxygen's partial reduction pathways.
2. What Is Their Role in Tissue Health?
ROS play a dual role in tissue health, acting as signaling molecules at physiological levels while causing damage when excessive. At low to moderate concentrations, ROS function as redox messengers in intracellular signaling pathways, regulating processes essential for tissue maintenance and repair.
In healthy tissues, ROS contribute to immune responses by facilitating phagocytosis and microbial killing in neutrophils and macrophages. For example, the respiratory burst in phagocytes generates superoxide via NADPH oxidase to combat pathogens. ROS also modulate cell proliferation, differentiation, and migration through activation of transcription factors like NF-κB and AP-1, which regulate genes involved in growth and survival. In wound healing, low-level ROS promote angiogenesis, collagen synthesis, and epithelialization by stimulating vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF).
Conversely, chronic elevation of ROS leads to oxidative stress, implicated in tissue pathology. Excessive ROS oxidize lipids (forming malondialdehyde), proteins (carbonylation), and DNA (8-oxoguanine lesions), contributing to inflammation, fibrosis, and cell death. In diseases like atherosclerosis, diabetes, and cancer, ROS exacerbate tissue damage by promoting endothelial dysfunction, insulin resistance, and mutagenesis, respectively.
Tissue-specific roles vary; in neural tissues, ROS influence synaptic plasticity but excess contributes to neurodegeneration. In musculoskeletal tissues, balanced ROS support muscle contraction and repair, while overload leads to sarcopenia.
Overall, ROS are indispensable for tissue homeostasis but require stringent control to prevent deleterious effects.
3. How Does PBM Produce ROS?
Photobiomodulation (PBM) produces ROS primarily through mitochondrial mechanisms, where light absorption alters electron transport and redox states. The primary chromophore is cytochrome c oxidase (CCO) in complex IV of the mitochondrial respiratory chain, which absorbs photons in the red/NIR range (e.g., 600–1000 nm).
Upon absorption, CCO dissociates inhibitory nitric oxide (NO), accelerating electron flow and oxygen reduction. This enhances ATP production but also leaks electrons, generating superoxide as a byproduct. The process is dose-dependent: low fluences (1–10 J/cm²) induce a brief ROS burst, while higher doses may suppress it.
Wavelength specificity influences ROS yield; 660 nm often increases ROS in normal cells, whereas 800–970 nm may reduce it in stressed cells by enhancing antioxidant defenses. In vitro studies show PBM elevates ROS in fibroblasts and neutrophils by disrupting mitochondrial membrane potential and altering fission-fusion dynamics.
Secondary pathways include activation of transient receptor potential (TRP) channels or opsins, leading to calcium influx and subsequent ROS generation via NADPH oxidase. In vivo, PBM modulates salivary ROS in oral mucositis patients, with effects varying by protocol.
Thus, PBM-induced ROS arise from enhanced mitochondrial activity, with context-dependent outcomes.
4. What Are the Effects of ROS Produced by PBM?
The ROS generated by PBM exert multifaceted effects, primarily beneficial, by acting as signaling mediators that enhance cellular resilience and repair. In normal cells, a modest ROS increase activates protective pathways, while in stressed cells, PBM often lowers ROS to alleviate oxidative burden.
Key effects include modulation of transcription factors like NF-κB, which ROS oxidize to promote gene expression for anti-inflammatory cytokines (e.g., IL-10) and antioxidants (e.g., SOD). This leads to reduced inflammation in models of arthritis, wounds, and neurodegeneration.
PBM-induced ROS also boost mitochondrial function, increasing ATP and restoring membrane potential, which supports cell proliferation and migration in wound healing. In immune cells, elevated ROS enhance antimicrobial activity, beneficial in immunocompromised states.
In cancer therapy adjuncts, controlled ROS from PBM sensitizes cells to treatments like photodynamic therapy, promoting apoptosis. Neuroprotective effects involve ROS-mediated activation of NRF2, upregulating antioxidants and reducing amyloid burden in Alzheimer's models.
Clinical evidence shows PBM reduces ROS in oral mucositis, improving tissue viability. Overall, these effects underscore PBM's therapeutic versatility.
5. Are There Any Adverse Effects Associated with ROS Produced by PBM?
While PBM is generally safe, adverse effects from ROS production can occur, primarily due to biphasic dose responses where excessive light leads to inhibitory or cytotoxic outcomes.
High fluences (>20 J/cm²) may overproduce ROS, causing mitochondrial uncoupling, ATP inhibition, and cell death via apoptosis or necrosis. In vitro, this manifests as reduced cell viability in fibroblasts or neurons exposed to prolonged irradiation.
In clinical contexts, potential risks include tissue overheating, (>45C or 113F) leading to thermal damage or exacerbated inflammation in sensitive areas like the brain. For cancer patients, uncontrolled ROS might promote tumor progression if PBM activates pro-survival pathways, though evidence is limited and contradictory.
Adverse effects are rare in standardized protocols; no significant malignancies or long-term damage reported in trials. However, variability in parameters (wavelength, dose) can lead to inconsistent outcomes, emphasizing the need for personalized dosing.
In summary, while minimal, adverse effects stem from ROS overload, mitigated by optimal parameters.
Conclusion
ROS are essential yet potentially harmful molecules whose modulation by PBM offers significant therapeutic promise. By generating controlled ROS, PBM enhances tissue repair, reduces inflammation, and supports cellular health, with applications spanning dermatology to neurology. However, the biphasic nature underscores the importance of precise dosing to avoid adverse effects like oxidative damage. Future research should focus on standardized protocols and long-term safety studies to fully harness this synergy.
References
1. Krumova, K., & Cosa, G. (2016). Overview of reactive oxygen species.
2. Bayr, H. (2005). Reactive oxygen species. Critical care medicine.
3. Orient, A., Donko, A., Szabo, A., Leto, T. L., et al. (2007). Novel sources of reactive oxygen species in the human body. Nephrology Dialysis Transplantation, 22(5), 1281.
4. Galli, F., Piroddi, M., Annetti, C., Aisa, C., Floridi, E., et al. (2005). Oxidative stress and reactive oxygen species.
5. Halliwell, B. (1991). Reactive oxygen species in living systems: source, biochemistry, and role in human disease. The American journal of medicine.
6. Flora, S. J. S. (2007). Role of free radicals and antioxidants in health and disease. Cellular and Molecular Biology.
7. Alfadda, A. A., & Sallam, R. M. (2012). Reactive oxygen species in health and disease. BioMed Research International.
8. Brieger, K., Schiavone, S., Miller, F. J., Jr., & Krause, K. H. (2012). Reactive oxygen species: from health to disease. Swiss Medical Weekly.
9. Castro, L., & Freeman, B. A. (2001). Reactive oxygen species in human health and disease. Nutrition.
10. Chen, Q., Wang, Q., Zhu, J., & Xiao, Q. (2018). Reactive oxygen species: key regulators in vascular health and diseases. British Journal of Pharmacology.
11. Hamblin, M. R. (2017). Mechanisms and applications of the anti-inflammatory effects of photobiomodulation. AIMS biophysics. https://pmc.ncbi.nlm.nih.gov/articles/PMC5523874/
12. Hamblin, M. R. (2018). Mechanisms and mitochondrial redox signaling in photobiomodulation. Photochemistry and photobiology.
13. Dompe, C., Moncrieff, L., Matys, J., et al. (2020). Photobiomodulation—underlying mechanism and clinical applications. Journal of clinical medicine, 9(6), 1724.
14. Bathini, M., Raghushaker, C. R., & Mahato, K. K. (2022). The molecular mechanisms of action of photobiomodulation against neurodegenerative diseases: a systematic review. Cellular and Molecular Neurobiology.
15. De Freitas, L. F., & Hamblin, M. R. (2016). Proposed mechanisms of photobiomodulation or low-level light therapy. IEEE Journal of selected topics in quantum electronics.
16. Amaroli, A., Pasquale, C., Zekiy, A., et al. (2021). Photobiomodulation and oxidative stress: 980 nm diode laser light regulates mitochondrial activity and reactive oxygen species production. Oxidative Medicine and Cellular Longevity.
17. Engel, K. W., Khan, I., & Arany, P. R. (2016). Cell lineage responses to photobiomodulation therapy. Journal of Biophotonics.
18. Rupel, K., Zupin, L., Colliva, A., Kamada, A., et al. (2018). Photobiomodulation at Multiple Wavelengths Differentially Modulates Oxidative Stress In Vitro and In Vivo. Oxidative medicine and cellular longevity.
19. Courtois, E., Bouleftour, W., Guy, J. B., Louati, S., et al. (2021). Mechanisms of PhotoBioModulation (PBM) focused on oral mucositis prevention and treatment: a scoping review. BMC Oral Health.
20. Safian, F., Novin, M. G., Nazarian, H., Mofarahe, Z. S., et al. (2021). Photobiomodulation preconditioned human semen protects sperm cells against detrimental effects of cryopreservation. Cryobiology.
21. Bensadoun, R. J., Nair, R. G., & Robijns, J. (2020). Photobiomodulation for side effects of cancer therapy. Photobiomodulation, photomedicine, and laser surgery.
22. Amaroli, A., Ravera, S., Baldini, F., Benedicenti, S., et al. (2019). Photobiomodulation with 808-nm diode laser light promotes wound healing of human endothelial cells through increased reactive oxygen species production. Lasers in Medical Science.
23. Dunnill, C., Patton, T., Brennan, J., Barrett, J., et al. (2017). Reactive oxygen species (ROS) and wound healing: The functional role of ROS and emerging ROS‐modulating technologies for augmentation of the healing process. International Wound Journal.
24. Bryan, N., Ahswin, H., Smart, N., Bayon, Y., Wohlert, S., et al. (2012). Reactive oxygen species (ROS)–a family of fate deciding molecules pivotal in constructive inflammation and wound healing. European Cell.
25. Polaka, S., Katare, P., Pawar, B., Vasdev, N., Gupta, T., et al. (2022). Emerging ROS-modulating technologies for augmentation of the wound healing process. ACS Omega.
26. Hunt, M., Torres, M., Bachar-Wikstrom, E., et al. (2024). Cellular and molecular roles of reactive oxygen species in wound healing. Communications Biology.
27. Deng, Z., Shi, F., Zhou, Z., Sun, F., Sun, M. H., Sun, Q., et al. (2019). M1 macrophage mediated increased reactive oxygen species (ROS) influence wound healing via the MAPK signaling in vitro and in vivo. Toxicology and Applied Pharmacology.
28. Nie, F., Hao, S., Ji, Y., Zhang, Y., Sun, H., & Will, M. (2023). Biphasic dose response in the anti-inflammation experiment of PBM. Lasers in medical science.
29. Luna, G. L. F., & de Andrade, A. L. M. (2020). Biphasic dose/response of photobiomodulation therapy on culture of human fibroblasts. Photobiomodulation, Photomedicine, and Laser Surgery.
30. Hu, J., Dong, X., Lv, Y., Hu, D., Fei, D., Dong, H., & Liu, B. (2024). Biphasic photobiomodulation of inflammation in mouse models of common wounds, infected wounds, and diabetic wounds. Journal of Photochemistry and Photobiology B: Biology.
31. Salehpour, F., Sadigh-Eteghad, S., & Mahmoudi, J. (2023). Biphasic Dose–response in Photobiomodulation of Neuronal Cells and the Brain. Photobiomodulation for the Brain.
32. Chang, C. Y., Aviña, A. E., Chang, C. J., & Lu, L. S. (2024). Exploring the biphasic dose-response effects of photobiomodulation on the viability, migration, and extracellular vesicle secretion of human adipose mesenchymal…. Journal of Photochemistry and Photobiology B: Biology.
